Operations Guy
Supreme Overlord
- 146
- 39
- 28
The hetastarches (Hextend and Hespan) got a pretty good ride about 10 years ago because they were seen as a clean (non blood product) quick volume expander that stayed intravascular (about 40% of the infused volume over 24 hr). I used them a lot but they were implicated with AKI in critical patients and bleeding with doses over 20 or so ml/kg. But some of that data was from animal models and I think the Europeans made a statement along those that more or less ended it's use. The FDA put out a warning and that was that. Too bad, to, because it was really useful.
Of course cause the European Medical and FDA opinions was based on civilian application and not it's designed application. It's application is proven and shown to be successful. Also European Medical and FDA groups where testing it on sepsis patients and patients already with one foot in the grave. I found its proper application outweighed all risk. The target of the application was healthy younger males with massive blood loss not little old ladies.